Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy

References

• HattonMPRubinPAThe pathophysiology of thyroid-associated ophthalmopathyOphthalmol Clin North Am200215111311912064074
   PubMedGoogle Scholar
• El-KaissiSFraumanAGWallJRThyroid-associated ophthalmopathy: a practical guide to classification, natural history and managementIntern Med J200434848249115317547
   PubMed Web of Science ®Google Scholar
• SteinJDChildersDGuptaSRisk factors for developing thyroid-associated ophthalmopathy among individuals with Graves diseaseJAMA Ophthalmol2015133329029625502604
   PubMed Web of Science ®Google Scholar
• HigashiyamaTNishidaYMorinoKUse of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathyJpn J Ophthalmol201559212413025448468
   PubMed Web of Science ®Google Scholar
• HigashiyamaTIwasaMOhjiMQuantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensitySci Rep2017711687429203853
   PubMed Web of Science ®Google Scholar
• MurakamiYKanamotoTTuboiTMaedaTInoueYEvaluation of extraocular muscle enlargement in dysthyroid ophthalmopathyJpn J Ophthalmol200145662262711754905
   PubMed Web of Science ®Google Scholar
• PrummelMFBakkerAWiersingaWMMulti-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European Group on Graves’ Orbitopathy experienceEur J Endocrinol2003148549149512720530
   PubMed Web of Science ®Google Scholar
• BahnRSGraves’ ophthalmopathyN Engl J Med2010362872673820181974
   PubMed Web of Science ®Google Scholar
• HiromatsuYEguchiHTaniJKasaokaMTeshimaYGraves’ ophthalmopathy: epidemiology and natural historyIntern Med201453535336024583420
   PubMed Web of Science ®Google Scholar
• LehmannGMFeldonSESmithTJPhippsRPImmune mechanisms in thyroid eye diseaseThyroid200818995996518752427
   PubMed Web of Science ®Google Scholar
• BartalenaLBaldeschiLDickinsonAConsensus statement of the European Group on Graves’ Orbitopathy (EUGOGO) on management of GOEur J Endocrinol2008158327328518299459
   PubMed Web of Science ®Google Scholar
• TortoraFPrudenteMCirilloMDiagnostic accuracy of short-time inversion recovery sequence in graves’ ophthalmopathy before and after prednisone treatmentNeuroradiology201456535336124573324
   PubMed Web of Science ®Google Scholar
• HigashiyamaTNishidaYOhjiMRelationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapyClin Ophthalmol20161072172927143850
   PubMed Web of Science ®Google Scholar
• BartalenaLBaldeschiLBoboridisKThe 2016 European thyroid association/european group on graves’ orbitopathy guidelines for the management of graves’ orbitopathyEur Thyroid J20165192627099835
   PubMed Web of Science ®Google Scholar
• HigashiyamaTNishidaYOhjiMChanges of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapyJpn J Ophthalmol201559643043526321629
   PubMed Web of Science ®Google Scholar
• OhtsukaKSatoAKawaguchiSHashimotoMSuzukiYEffect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for graves’ ophthalmopathyJpn J Ophthalmol200246556356712457917
   PubMed Web of Science ®Google Scholar
• RichterDFStoffAOlivariNTranspalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 yearsPlast Reconstr Surg2007120110912317572552
   PubMed Web of Science ®Google Scholar
• PratMCBraunsteinALDagi GlassLRKazimMOrbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selectionOphthalmic Plast Reconstr Surg201531321521825198394
   PubMed Web of Science ®Google Scholar
• SmithTJKahalyGJEzraDGTeprotumumab for thyroid-associated ophthalmopathyN Engl J Med2017376181748176128467880
   PubMed Web of Science ®Google Scholar
• WangKXuLYuanZIntraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in ChinaBMC Ophthalmol2014142124568617
   PubMed Web of Science ®Google Scholar
• LiTLindsleyKRouseBComparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysisOphthalmology2016123112914026526633
   PubMed Web of Science ®Google Scholar
• YangHKParkKHKimTWKimDMDeepening of eyelid superior sulcus during topical travoprost treatmentJpn J Ophthalmol200953217617919333704
   PubMed Web of Science ®Google Scholar
• YoshinoTFukuchiTToganoTEyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment casesJpn J Ophthalmol201357217217823208023
   PubMed Web of Science ®Google Scholar
• SakataRShiratoSMiyataKAiharaMIncidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solutionJpn J Ophthalmol201458221221724390604
   PubMed Web of Science ®Google Scholar
• NakakuraSYamamotoMTeraoEProstaglandin-associated periorbitopathy in latanoprost usersClin Ophthalmol20159515625565768
   PubMedGoogle Scholar
• RabinowitzMPKatzLJMosterMRUnilateral prostaglandin-associated periorbitopathy: a syndrome involving upper eyelid retraction distinguishable from the aging sunken eyelidOphthalmic Plast Reconstr Surg201531537337825393907
   PubMed Web of Science ®Google Scholar
• InoueKShiokawaMWakakuraMTomitaGDeepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogsJ Glaucoma201322862663122936280
   PubMed Web of Science ®Google Scholar
• KucukevciliogluMBayerAUysalYAltinsoyHIProstaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprostClin Exp Ophthalmol201442212613123844550
   PubMed Web of Science ®Google Scholar
• JayaprakasamAGhazi-NouriSPeriorbital fat atrophy – an unfamiliar side effect of prostaglandin analoguesOrbit201029635735921158579
   PubMedGoogle Scholar
• NishidaYTianSIsbergBSignificance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathyGraefes Arch Clin Exp Ophthalmol2002240751552012136278
   PubMed Web of Science ®Google Scholar
• TianSNishidaYIsbergBLennerstrandGMRI measurements of normal extraocular muscles and other orbital structuresGraefes Arch Clin Exp Ophthalmol2000238539340410901470
   PubMed Web of Science ®Google Scholar
• NishidaYTianSIsbergBTallstedtLLennerstrandGMRI measurements of orbital tissues in dysthyroid ophthalmopathyGraefes Arch Clin Exp Ophthalmol20012391182483111789862
   PubMed Web of Science ®Google Scholar
• LennerstrandGTianSIsbergBMagnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the diseaseActa Ophthalmol Scand200785219220117305734
   PubMedGoogle Scholar
• PeysterRGGinsbergFSilberJHAdlerLPExophthalmos caused by excessive fat: ct volumetric analysis and differential diagnosisAJR Am J Roentgenol198614634594643484861
   PubMed Web of Science ®Google Scholar
• ArnerPHuman fat cell lipolysis: biochemistry, regulation and clinical roleBest Pract Res Clin Endocrinol Metab200519447148216311212
   PubMed Web of Science ®Google Scholar
• MillerCWCasimirDANtambiJMThe mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alphaEndocrinology199613712564156508940395
   PubMed Web of Science ®Google Scholar
• SerreroGLepakNMProstaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined mediumBiochem Biophys Res Commun199723312002029144422
   PubMed Web of Science ®Google Scholar
• LiuLClipstoneNAProstaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathwayJ Cell Biochem2007100116117316888802
   PubMed Web of Science ®Google Scholar
• TaketaniYYamagishiRFujishiroTActivation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathyInvest Ophthalmol Vis Sci20145531269127624508785
   PubMed Web of Science ®Google Scholar
• HanRTsuiSSmithTJUp-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expressionJ Biol Chem200227719163551636411847219
   PubMed Web of Science ®Google Scholar
• KoumasLSmithTJPhippsRPFibroblast subsets in the human orbit: Thy-1+ and Thy-1– subpopulations exhibit distinct phenotypesEur J Immunol200232247748511813166
   PubMed Web of Science ®Google Scholar
• FangSHuangYZhongSRegulation of orbital fibrosis and adipogenesis by pathogenic th17 cells in graves orbitopathyJ Clin Endocrinol Metab2017102114273428328938397
   PubMed Web of Science ®Google Scholar